- Home
- LEGN vs LAZ Comparison
LEGN vs LAZ Comparison
Compare LEGN & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- LAZ
- Stock Information
- Founded
- LEGN 2014
- LAZ 1848
- Country
- LEGN United States
- LAZ United States
- Employees
- LEGN N/A
- LAZ N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- LAZ Investment Managers
- Sector
- LEGN Health Care
- LAZ Finance
- Exchange
- LEGN Nasdaq
- LAZ Nasdaq
- Market Cap
- LEGN 5.4B
- LAZ 5.1B
- IPO Year
- LEGN 2020
- LAZ 2005
- Fundamental
- Price
- LEGN $38.80
- LAZ $50.17
- Analyst Decision
- LEGN Strong Buy
- LAZ Hold
- Analyst Count
- LEGN 11
- LAZ 9
- Target Price
- LEGN $74.60
- LAZ $52.88
- AVG Volume (30 Days)
- LEGN 1.4M
- LAZ 1.1M
- Earning Date
- LEGN 08-11-2025
- LAZ 07-24-2025
- Dividend Yield
- LEGN N/A
- LAZ 3.98%
- EPS Growth
- LEGN N/A
- LAZ 80.92
- EPS
- LEGN N/A
- LAZ 2.90
- Revenue
- LEGN $728,303,000.00
- LAZ $3,061,171,000.00
- Revenue This Year
- LEGN $65.33
- LAZ $0.43
- Revenue Next Year
- LEGN $54.68
- LAZ $15.61
- P/E Ratio
- LEGN N/A
- LAZ $17.33
- Revenue Growth
- LEGN 112.46
- LAZ 10.05
- 52 Week Low
- LEGN $27.34
- LAZ $31.97
- 52 Week High
- LEGN $59.62
- LAZ $61.14
- Technical
- Relative Strength Index (RSI)
- LEGN 47.38
- LAZ 45.15
- Support Level
- LEGN $38.53
- LAZ $52.60
- Resistance Level
- LEGN $45.30
- LAZ $57.00
- Average True Range (ATR)
- LEGN 1.76
- LAZ 1.71
- MACD
- LEGN -0.61
- LAZ -0.61
- Stochastic Oscillator
- LEGN 9.73
- LAZ 12.44
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About LAZ Lazard Inc.
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.